COMPASS Pathways plc
CMPS · XNASCIK 1816590fmd_0YNMQX271QSA7E7SZXTZGW8EKGManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2019 to Sep 30, 2026, 28 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Research and development | 13 | 23 | 44 | 65 | 88 | 119 | 118 |
| Total operating expenses | 21 | 51 | 83 | 110 | 137 | 178 | 179 |
| Operating income | (21) | (51) | (83) | (110) | (137) | (178) | (179) |
| Interest expense | – | – | 0 | 0 | 2 | 4 | 5 |
| Interest and investment income | – | – | – | – | 5 | 8 | 7 |
| Other non-operating income (expense) | 2 | (9) | 12 | 19 | 19 | 25 | (111) |
| Income before taxes | (20) | (60) | (72) | (91) | (118) | (154) | (290) |
| Income tax expense | 0 | 0 | 0 | 0 | 1 | 2 | (2) |
| Net income from continuing operations | (20) | (60) | (72) | (92) | (118) | (155) | (288) |
| Net income | (20) | (60) | (72) | (92) | (118) | (155) | (288) |
| Net income to common shareholders | – | (60) | (72) | (92) | (118) | – | – |